Cue Biopharma (CUE) Revenue (2018 - 2026)
Cue Biopharma's Revenue came in at $7.88 million for Q2 2026, up 166.7% from $2.95 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Revenue (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cue Biopharma reported Revenue of $34.92 million, up 321.4% year-over-year; for FY2025, it was $27.47 million, up 195.7% from FY2024.
- Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 54.2% (FY2020 to FY2025).
- Going back by year, Revenue was $9.29 million in FY2024 (+69.2%), $5.49 million in FY2023 (+341.0%), $1.25 million in FY2022 (-91.7%) and $14.94 million in FY2021 (+373.7%).
- The five-year range for quarterly Revenue is $26,000 (Q2 2022) to $21.94 million (Q4 2025).
- Year-over-year, Revenue increased in three of the last six quarters, with growth averaging 18.7%.
- The fastest year-over-year change in Revenue over five years came in Q1 2024 (growth of 818.2%), and the weakest in Q2 2022 (a decline of 99.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Cue Biopharma | 118.99 Mn | 28.26 Mn | - | 7.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.88 Mn |
| Dec 31, 2025 | 21.94 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 421,000.00 |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 8.25 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 2.74 Mn |
API Access
Cue Biopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();